It’s easier than ever for doctors to prescribe a key medicine for opioid addiction since the U.S. government lifted an obstacle last year. But despite the looser restrictions and the ongoing overdose crisis, a new study finds little change in the number of people taking the medication. Researchers analyzed prescriptions filled by U.S. pharmacies for the treatment drug buprenorphine. The number of prescribers rose last year after doctors no longer needed to get a special waiver to prescribe the drug, while the number of patients filling prescriptions barely budged. It may take more than one year to see a bigger increase in patients, said study co-author Dr. Kao-Ping Chua of the University of Michigan Medical School. “There are so many other barriers to prescribing that we have to address,” said Chua. The findings were published Wednesday in the New England Journal of Medicine. |
Two US Navy sailors arrested on charges tied to national security and ChinaChina News Jack Ma: Alibaba's founder turns up in Japan as college professorVOX POPULI: Like Nobita in ‘Doraemon,’ we should never give up on ourselves'Barbie' makes history with $1 billion at the box officeShortland Street: Fate of muchHainan island: Known as 'China's Hawaii,' the vacation hotspot is also a strategic military baseChina News Jack Ma: Alibaba's founder turns up in Japan as college professorVOX POPULI: Manga artist exposes the juicy dynamics behind ‘oden’ factionsPublic servants want to know if management positions will be on the chopping blockVOX POPULI: Early spring fills us with regret at missing out on winter’s charms